Webinar- Living with Type II Diabetes

This Webinar- Living with T2 Diabetes, is presented by Henry Anhalt, DO, Pediatric Endocrinologist and Executive Director of Medical Affairs at Proventionbio. Dr. Anhalt has been a medical advisor of the Turner Syndrome Foundation since 2009, and remains steadfast in treating patients.

Women with Turner Syndrome are at greater risk for developing T2 diabetes. In this presentation you will listen and learn about why there is a greater risk. You will learn about some simple steps you can take to reduce your chances of developing T2 diabetes.

In this presentation, you will learn about:

  • Background epidemiology
  • Pathophysiology
  • Current available treatments
  • What can a person do to reduce risk

Webinar Link:
Check the email you provided to receive the webinar link.

Cost:
If you cannot make a donation, add $1.00 paid by check to process your request. Note, you will not be charged and you will receive access to the webinar. If you can give today, please do so. Our mission needs your support.

About Henry Anhalt:
Dr. Henry Anhalt is a board-certified pediatric endocrinologist and physician scientist who has served in executive roles with increasing responsibility during his career spanning academia, bio- pharma, non-profit and most recently at Proventionbio where he serves as executive director of medical affairs.  Dr. Anhalt attended the New York College of Osteopathic Medicine (DO). Upon graduation he did a rotating internship at The Brookdale University Hospital Center (SUNY Downstate), and his pediatric residency and chief residency at Winthrop University Hospital (SUNY Stony Brook). Dr. Anhalt completed his pediatric endocrinology fellowship at Lucille Packard Children’s Hospital at Stanford University. After returning to the east coast, Dr. Anhalt served as division chief at the Brooklyn Hospital Center, Maimonides Children’s Hospital, and the St. Barnabas Medical Center. In 2008 he joined Animas corporation (Johnson and Johnson) where he was Chief Medical Officer and responsible for the development of an artificial pancreas system. While at Sanofi he served as North American medical affairs lead responsible for launching Toujeo, which was followed by his appointment as Chief Medical Officer at the T1D Exchange. He joined Science 37, a decentralized clinical trial company where he served a vice president and joined Proventionbio in December 2020.Dr. Anhalt has served on and chaired several committees within the Endocrine Society including the Hormone Health Network, and Advocacy and Public Outreach Core Committee. Most recently he served on the Endocrine Society Board of Directors. He serves on the editorial board of Endocrine News, has authored over 40 original manuscripts, dozens of abstracts, consensus statements, textbook chapters and clinical reviews. He serves on the Board of Directors of Insulin for Life-USA which provides insulin and disease management supplies free of charge to emerging countries and in the US during periods of natural disasters. In addition, he sits on the Board of Directors of Camp Nejeda for children with T1D.    He maintains a pediatric endocrinology practice in Hackensack, NJ.

 

Webinar Diabetes

View Webinar on Demand

Shopping Cart

Support Turner Syndrome Awareness

February and every day awareness begins with you!